University of Leicester
Browse
1-s2.0-S1751991822000316-main.pdf (2.94 MB)

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Download (2.94 MB)
journal contribution
posted on 2024-01-26, 10:25 authored by S Seidu, X Cos, S Brunton, SB Harris, SPO Jansson, M Mata-Cases, AMJ Neijens, P Topsever, K Khunti
Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimising glycaemic control is increasing, especially on the frontlines of patient care. In many countries, most patients with type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the challenge of the growing plethora of available treatment options for managing hyperglycaemia, leading to difficultly in making treatment decisions and contributing to treatment and therapeutic inertia. This position statement offers a simple and patient-centred clinical decision-making model with practical treatment recommendations that can be widely implemented by primary care clinicians worldwide through shared-decision conversations with their patients. It highlights the importance of managing cardiovascular disease and elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and treatment strategies that connect patients with the most effective care.

History

Author affiliation

Diabetes Research Centre, University of Leicester

Version

  • VoR (Version of Record)

Published in

Primary Care Diabetes

Volume

16

Issue

2

Pagination

223-244

Publisher

Elsevier BV

issn

1751-9918

eissn

1878-0210

Copyright date

2022

Available date

2024-01-26

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC